TuHURA Biosciences, Inc./NV
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation NV
Business Address 10500 UNIVERSITY CENTER DR., TAMPA, FL, 33612
Mailing Address 10500 UNIVERSITY CENTER DR., TAMPA, FL, 33612
Phone 813-875-6600
Fiscal Year End 1231
EIN 990360497
Financial Overview
FY2024
$5.92M
Total Liabilities
$14.59M
Stockholders' Equity
$12.66M
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | January 30, 2026 | View on SEC |
| 4 Insider stock transaction report | January 8, 2026 | View on SEC |
| 4 Insider stock transaction report | January 8, 2026 | View on SEC |
| 4 Insider stock transaction report | December 17, 2025 | View on SEC |
| 4 Insider stock transaction report | December 17, 2025 | View on SEC |
| 424B5 Prospectus supplement | December 10, 2025 | View on SEC |
| 8-K Current report of material events | December 10, 2025 | View on SEC |
| 8-K Current report of material events | December 5, 2025 | View on SEC |
| 8-K Current report of material events | November 25, 2025 | View on SEC |
| 8-K Current report of material events | November 18, 2025 | View on SEC |
Material Events
8-K Financial Distress January 30, 2026
High Impact
- Notice does not immediately affect the Company’s business, operations, or reporting requirements.
- Notice has no immediate effect on business operations or financial condition.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.